Coraline Duménil

Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis

M. Duruisseaux, Anna Martínez‐Cardús, María Eréndira Calleja-Cervantes et al. · The Lancet Respiratory Medicine · 2018 · 222 citations · Full text

Medicine, Oncology, Epigenetics +16

Predictive role of plasmatic biomarkers in advanced non-small cell lung cancer treated by nivolumab

Adrien Costantini, Catherine Julié, Coraline Duménil et al. · OncoImmunology · 2018 · 173 citations · Full text

Medicine, Immunology, Oncology +17

Role of antibiotic use, plasma citrulline and blood microbiome in advanced non-small cell lung cancer patients treated with nivolumab

Julia Ouaknine Krief, Pierre Helly de Tauriers, Coraline Duménil et al. · Journal for ImmunoTherapy of Cancer · 2019 · 97 citations · Full text

Life Sciences, Immunology, Oncology +16

Circulating tumor DNA evaluated by Next-Generation Sequencing is predictive of tumor response and prolonged clinical benefit with nivolumab in advanced non-small cell lung cancer

Etienne Giroux‐Leprieur, Guillaume Herbretau, Coraline Duménil et al. · OncoImmunology · 2018 · 84 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Clinical factors associated with early progression and grade 3–4 toxicity in patients with advanced non-small-cell lung cancers treated with nivolumab

Coraline Duménil, Marie-Ange Massiani, Jennifer Dumoulin et al. · PLoS ONE · 2018 · 58 citations · Full text

Medicine, Oncology, Pharmacotherapy +17